Platinum-based chemotherapy agents, such as cisplatin and oxaliplatin, have demonstrated efficacy in treating a range of malignancies. However, their inherent toxicity necessitates the exploration of alternative or adjunctive therapeutic modalities. Paclitaxel and docetaxel, constituting the taxane class, have emerged as potent antitumor agents wit